| Epilepsy Res
| [0004]
|
| Milnacipran for neuropathic pain and fibromyalgia in adults
| [0005]
|
| Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
| [0005]
|
| Fibromyalgia drugs: successes or failures?
| [0006]
|
| An antinociceptive role for substance P in acid-induced chronic muscle pain
| [0007]
|
| Roles of proton-sensing receptors in the transition from acute to chronic pain
| [0007]
|
| NK1 (substance P) receptor antagonists - why are they not analgesic in humans?
| [0007]
|
| Methods and compositions for treating pain
| [0008]
|
| Acid-sensing ion channels in postoperative pain
| [0008]
|
| An antinociceptive role for substance P in acid-induced chronic muscle pain
| [0008]
|
| Guidance for Industry and Reviewers Estimating the Safe Starting Dose in Clinical Trials for Therapeutics in Adult Healthy Volunteers
| [0039]
|
| Design and synthesis of novel dual-action compounds targeting the adenosine A2A receptor and adenosine transporter for neuroprotection
| [0058]
[0129]
|
| Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia
| [0169]
|